Genitourinary Cancer,RCC (Renal Cell Carcinoma) Nivo-Ipi + Cabo: Optimal First-Line Treatment in mRCC Jul 10, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) PAPMET2 Trial: Efficacy of Cabo/Atezo vs Cabo in PRCC Jul 10, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) IMDs: Prospective Treatment Tool in RCC & Drug Development Jul 09, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) FSP1: Promising Target for Chromophobe Therapy in RCC Jul 09, 2024
Bladder Cancer,Genitourinary Cancer Prognostic Model of Disulfidptosis-Related lncRNAs in BLCA Jul 09, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Clinical-Genomic Insights into RCC Immunotherapy Jul 09, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) First-Line Efficacy of Bot/Bal in mccRCC: ARCITECT Trial Jul 09, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Assessing Pembro + Lenvatinib in RCC: Focus on BM Jul 09, 2024
